Research ArticleArticle
Therapeutic Potential of Nitric Oxide-Modified Drugs in Colon Cancer Cells
Marija Mojic, Sanja Mijatovic, Danijela Maksimovic-Ivanic, Djordje Miljkovic, Stanislava Stosic-Grujicic, Marija Stankovic, Katia Mangano, Salvatore Travali, Marco Donia, Paolo Fagone, Mai-Britt Zocca, Yousef Al-Abed, James A. McCubrey and Ferdinando Nicoletti
Molecular Pharmacology October 2012, 82 (4) 700-710; DOI: https://doi.org/10.1124/mol.112.077842
Marija Mojic
Department of Immunology, Institute for Biological Research “Sinisa Stankovic” (M.M., S.M., D.M.-I., D.M., S.S.-G.) and Institute of Molecular Genetics and Genetic Engineering (M.S.), Belgrade University, Belgrade, Serbia (M.S.); Department of Biomedical Sciences, University of Catania, Catania, Italy (K.M., S.T., M.D., P.F.); OncoNOx Aps, Copenhagen, Denmark (M.-B.Z., F.N.); Laboratory of Medicinal Chemistry, North Shore Long Island Jewish Health System, Long Island, New York (Y.A.-A.); and Department of Microbiology and Immunology, East Carolina University, Greenville, North Carolina (J.A.M.)
Sanja Mijatovic
Department of Immunology, Institute for Biological Research “Sinisa Stankovic” (M.M., S.M., D.M.-I., D.M., S.S.-G.) and Institute of Molecular Genetics and Genetic Engineering (M.S.), Belgrade University, Belgrade, Serbia (M.S.); Department of Biomedical Sciences, University of Catania, Catania, Italy (K.M., S.T., M.D., P.F.); OncoNOx Aps, Copenhagen, Denmark (M.-B.Z., F.N.); Laboratory of Medicinal Chemistry, North Shore Long Island Jewish Health System, Long Island, New York (Y.A.-A.); and Department of Microbiology and Immunology, East Carolina University, Greenville, North Carolina (J.A.M.)
Danijela Maksimovic-Ivanic
Department of Immunology, Institute for Biological Research “Sinisa Stankovic” (M.M., S.M., D.M.-I., D.M., S.S.-G.) and Institute of Molecular Genetics and Genetic Engineering (M.S.), Belgrade University, Belgrade, Serbia (M.S.); Department of Biomedical Sciences, University of Catania, Catania, Italy (K.M., S.T., M.D., P.F.); OncoNOx Aps, Copenhagen, Denmark (M.-B.Z., F.N.); Laboratory of Medicinal Chemistry, North Shore Long Island Jewish Health System, Long Island, New York (Y.A.-A.); and Department of Microbiology and Immunology, East Carolina University, Greenville, North Carolina (J.A.M.)
Djordje Miljkovic
Department of Immunology, Institute for Biological Research “Sinisa Stankovic” (M.M., S.M., D.M.-I., D.M., S.S.-G.) and Institute of Molecular Genetics and Genetic Engineering (M.S.), Belgrade University, Belgrade, Serbia (M.S.); Department of Biomedical Sciences, University of Catania, Catania, Italy (K.M., S.T., M.D., P.F.); OncoNOx Aps, Copenhagen, Denmark (M.-B.Z., F.N.); Laboratory of Medicinal Chemistry, North Shore Long Island Jewish Health System, Long Island, New York (Y.A.-A.); and Department of Microbiology and Immunology, East Carolina University, Greenville, North Carolina (J.A.M.)
Stanislava Stosic-Grujicic
Department of Immunology, Institute for Biological Research “Sinisa Stankovic” (M.M., S.M., D.M.-I., D.M., S.S.-G.) and Institute of Molecular Genetics and Genetic Engineering (M.S.), Belgrade University, Belgrade, Serbia (M.S.); Department of Biomedical Sciences, University of Catania, Catania, Italy (K.M., S.T., M.D., P.F.); OncoNOx Aps, Copenhagen, Denmark (M.-B.Z., F.N.); Laboratory of Medicinal Chemistry, North Shore Long Island Jewish Health System, Long Island, New York (Y.A.-A.); and Department of Microbiology and Immunology, East Carolina University, Greenville, North Carolina (J.A.M.)
Marija Stankovic
Department of Immunology, Institute for Biological Research “Sinisa Stankovic” (M.M., S.M., D.M.-I., D.M., S.S.-G.) and Institute of Molecular Genetics and Genetic Engineering (M.S.), Belgrade University, Belgrade, Serbia (M.S.); Department of Biomedical Sciences, University of Catania, Catania, Italy (K.M., S.T., M.D., P.F.); OncoNOx Aps, Copenhagen, Denmark (M.-B.Z., F.N.); Laboratory of Medicinal Chemistry, North Shore Long Island Jewish Health System, Long Island, New York (Y.A.-A.); and Department of Microbiology and Immunology, East Carolina University, Greenville, North Carolina (J.A.M.)
Katia Mangano
Department of Immunology, Institute for Biological Research “Sinisa Stankovic” (M.M., S.M., D.M.-I., D.M., S.S.-G.) and Institute of Molecular Genetics and Genetic Engineering (M.S.), Belgrade University, Belgrade, Serbia (M.S.); Department of Biomedical Sciences, University of Catania, Catania, Italy (K.M., S.T., M.D., P.F.); OncoNOx Aps, Copenhagen, Denmark (M.-B.Z., F.N.); Laboratory of Medicinal Chemistry, North Shore Long Island Jewish Health System, Long Island, New York (Y.A.-A.); and Department of Microbiology and Immunology, East Carolina University, Greenville, North Carolina (J.A.M.)
Salvatore Travali
Department of Immunology, Institute for Biological Research “Sinisa Stankovic” (M.M., S.M., D.M.-I., D.M., S.S.-G.) and Institute of Molecular Genetics and Genetic Engineering (M.S.), Belgrade University, Belgrade, Serbia (M.S.); Department of Biomedical Sciences, University of Catania, Catania, Italy (K.M., S.T., M.D., P.F.); OncoNOx Aps, Copenhagen, Denmark (M.-B.Z., F.N.); Laboratory of Medicinal Chemistry, North Shore Long Island Jewish Health System, Long Island, New York (Y.A.-A.); and Department of Microbiology and Immunology, East Carolina University, Greenville, North Carolina (J.A.M.)
Marco Donia
Department of Immunology, Institute for Biological Research “Sinisa Stankovic” (M.M., S.M., D.M.-I., D.M., S.S.-G.) and Institute of Molecular Genetics and Genetic Engineering (M.S.), Belgrade University, Belgrade, Serbia (M.S.); Department of Biomedical Sciences, University of Catania, Catania, Italy (K.M., S.T., M.D., P.F.); OncoNOx Aps, Copenhagen, Denmark (M.-B.Z., F.N.); Laboratory of Medicinal Chemistry, North Shore Long Island Jewish Health System, Long Island, New York (Y.A.-A.); and Department of Microbiology and Immunology, East Carolina University, Greenville, North Carolina (J.A.M.)
Paolo Fagone
Department of Immunology, Institute for Biological Research “Sinisa Stankovic” (M.M., S.M., D.M.-I., D.M., S.S.-G.) and Institute of Molecular Genetics and Genetic Engineering (M.S.), Belgrade University, Belgrade, Serbia (M.S.); Department of Biomedical Sciences, University of Catania, Catania, Italy (K.M., S.T., M.D., P.F.); OncoNOx Aps, Copenhagen, Denmark (M.-B.Z., F.N.); Laboratory of Medicinal Chemistry, North Shore Long Island Jewish Health System, Long Island, New York (Y.A.-A.); and Department of Microbiology and Immunology, East Carolina University, Greenville, North Carolina (J.A.M.)
Mai-Britt Zocca
Department of Immunology, Institute for Biological Research “Sinisa Stankovic” (M.M., S.M., D.M.-I., D.M., S.S.-G.) and Institute of Molecular Genetics and Genetic Engineering (M.S.), Belgrade University, Belgrade, Serbia (M.S.); Department of Biomedical Sciences, University of Catania, Catania, Italy (K.M., S.T., M.D., P.F.); OncoNOx Aps, Copenhagen, Denmark (M.-B.Z., F.N.); Laboratory of Medicinal Chemistry, North Shore Long Island Jewish Health System, Long Island, New York (Y.A.-A.); and Department of Microbiology and Immunology, East Carolina University, Greenville, North Carolina (J.A.M.)
Yousef Al-Abed
Department of Immunology, Institute for Biological Research “Sinisa Stankovic” (M.M., S.M., D.M.-I., D.M., S.S.-G.) and Institute of Molecular Genetics and Genetic Engineering (M.S.), Belgrade University, Belgrade, Serbia (M.S.); Department of Biomedical Sciences, University of Catania, Catania, Italy (K.M., S.T., M.D., P.F.); OncoNOx Aps, Copenhagen, Denmark (M.-B.Z., F.N.); Laboratory of Medicinal Chemistry, North Shore Long Island Jewish Health System, Long Island, New York (Y.A.-A.); and Department of Microbiology and Immunology, East Carolina University, Greenville, North Carolina (J.A.M.)
James A. McCubrey
Department of Immunology, Institute for Biological Research “Sinisa Stankovic” (M.M., S.M., D.M.-I., D.M., S.S.-G.) and Institute of Molecular Genetics and Genetic Engineering (M.S.), Belgrade University, Belgrade, Serbia (M.S.); Department of Biomedical Sciences, University of Catania, Catania, Italy (K.M., S.T., M.D., P.F.); OncoNOx Aps, Copenhagen, Denmark (M.-B.Z., F.N.); Laboratory of Medicinal Chemistry, North Shore Long Island Jewish Health System, Long Island, New York (Y.A.-A.); and Department of Microbiology and Immunology, East Carolina University, Greenville, North Carolina (J.A.M.)
Ferdinando Nicoletti
Department of Immunology, Institute for Biological Research “Sinisa Stankovic” (M.M., S.M., D.M.-I., D.M., S.S.-G.) and Institute of Molecular Genetics and Genetic Engineering (M.S.), Belgrade University, Belgrade, Serbia (M.S.); Department of Biomedical Sciences, University of Catania, Catania, Italy (K.M., S.T., M.D., P.F.); OncoNOx Aps, Copenhagen, Denmark (M.-B.Z., F.N.); Laboratory of Medicinal Chemistry, North Shore Long Island Jewish Health System, Long Island, New York (Y.A.-A.); and Department of Microbiology and Immunology, East Carolina University, Greenville, North Carolina (J.A.M.)
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Research ArticleArticle
GIT-27NO and Saq-NO Suppressed Colon Cancer Growth
Marija Mojic, Sanja Mijatovic, Danijela Maksimovic-Ivanic, Djordje Miljkovic, Stanislava Stosic-Grujicic, Marija Stankovic, Katia Mangano, Salvatore Travali, Marco Donia, Paolo Fagone, Mai-Britt Zocca, Yousef Al-Abed, James A. McCubrey and Ferdinando Nicoletti
Molecular Pharmacology October 1, 2012, 82 (4) 700-710; DOI: https://doi.org/10.1124/mol.112.077842
Research ArticleArticle
GIT-27NO and Saq-NO Suppressed Colon Cancer Growth
Marija Mojic, Sanja Mijatovic, Danijela Maksimovic-Ivanic, Djordje Miljkovic, Stanislava Stosic-Grujicic, Marija Stankovic, Katia Mangano, Salvatore Travali, Marco Donia, Paolo Fagone, Mai-Britt Zocca, Yousef Al-Abed, James A. McCubrey and Ferdinando Nicoletti
Molecular Pharmacology October 1, 2012, 82 (4) 700-710; DOI: https://doi.org/10.1124/mol.112.077842
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement